<DOC>
	<DOC>NCT00770796</DOC>
	<brief_summary>In this randomized study the investigators wish to explore the role of pre-procedural statin therapy for the prevention of contrast induced nephropathy in patients with moderate-to-severe renal dysfunction, submitted to elective coronary or angioplasty.</brief_summary>
	<brief_title>Statins for Prevention of Contrast Induced Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>patients with preangiographic estimated creatinine clearance &lt; 60 ml/min contrast medium administration within the previous 10 days endstage renal failure requiring dialysis refusal to give informed consent previous therapy with statin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Contrast induced nephropathy</keyword>
</DOC>